Ledger.Open graph →
SEC Form D · filed March 13, 2023

Volastra Therapeutics, Inc

Offering
$60.2M
Sold
$60.2M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
NEW YORK, NY
Type

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (20)

Stefan Z. Vitorovic · New York, NYDirectorCharles Hugh-Jones · New York, NYExec · DirectorSamuel Z. Bakhoum · New York, NYDirectorSandra Z. Peterson · New York, NYExec · DirectorTodd Kropp · Detroit, MIExec · DirectorDavid Dwaihy · Detroit, MIExec · DirectorPatrick P. Luo · San Francisco, CADirectorMichael Lasinski · Detroit, MIDirectorDiane Tager · New York, NYExecMichael Su · New York, NYExecAmy Schulman · Waltham, MADirectorLuc Dochez · Leiden, P7DirectorSai Fai Yip · Singapore, U0Exec · DirectorJohn F. Burke · ARLINGTON, VAExec · DirectorMeg Reynolds · Park City, UTDirectorHeather Solberg · Ames, IADirectorDiane Tager · New York, NYExecMichael Su · New York, NYExecAmy Schulman · Waltham, MADirectorLuc Dochez · Leiden, P7Director

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗